Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system?
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 22615544.
- Also identified by DOI 10.1371/journal.pmed.1001218 and PMC identifier 3352855.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
As part of a cluster of articles leading up to the 2012 World Health Report and critically reflecting on the theme of “no health without research,” Suerie Moon and colleagues argue for a global health R&D treaty to improve innovation in new medicines and strengthening affordability, sustainable financing, efficiency in innovation, and equitable health-centered governance.
Medical subject headings
- Biomedical Research
- Drug Discovery
- Health Services Accessibility
- Healthcare Disparities
- International Cooperation
- Neglected Diseases
- Pharmaceutical Preparations